Organ Preservation Market - Global Forecast 2025-2032

The organ preservation market is undergoing pivotal transformation as innovative technologies, evolving regulations, and strategic collaborations converge to enhance transplant outcomes and reimagine global healthcare delivery. Decision-makers face a complex landscape where advanced preservation solutions, robust supply chains, and value-driven partnerships are redefining growth and operational priorities.

Market Snapshot: Organ Preservation Market Size, Trends, and Growth Trajectory

The organ preservation market grew from USD 185.90 million in 2024 to USD 199.92 million in 2025. It is expected to continue its expansion at a CAGR of 7.96%, reaching USD 343.29 million by 2032. Surging global transplant volumes and the integration of cutting-edge preservation systems are accelerating market momentum. Demand is further driven by heightened clinical requirements and the quest for improved viability in organ transplantation.

Scope & Segmentation: Diverse Offerings, Methods, and Regional Coverage

This report provides an in-depth analysis of the organ preservation market, outlining key product types, end-users, applications, and regional dynamics:

• Offerings: Devices (Accessories, Perfusion Systems), Services (Training & Maintenance, Transplant Coordination), Solutions (Data Management & Analysis, Decision Support & Communication, Tracking & Monitoring)
• Preservation Methods: Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Static Cold Storage
• Organ Types: Heart, Kidney, Liver, Lung, Pancreas
• Applications: Research & Development, Transplantation, Transportation
• End Users: Hospitals, Organ Banks, Research Institutes, Transplant Centers
• Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Company Coverage: 21st Century Medicine, AVIONORD S.R.L., BioLife Solutions Inc., Bridge to Life Ltd., Carnamedica, Dr. Franz Köhler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Essential Pharmaceuticals (by Accord Healthcare Limited), Global Transplant Solutions, Hemarina SA, Institut Georges Lopez, Lifeline Scientific, Organ Preservation Solutions Ltd., OrganOx Limited, Paragonix Technologies, Preservation Solutions, S.A.L.F. S.p.A., SAS Advanced Life Solutions, ScubaTx Limited, TransMedics, TX Innovations B.V., Vascular Perfusion Solutions, XVIVO AB

Key Takeaways for Senior Decision-Makers

• The market is fueled by rising transplantation rates and the shift from static cold storage to sophisticated perfusion systems and real-time analytics platforms.
• Advanced data-driven solutions now empower healthcare professionals to predict organ viability and reduce the risk of post-transplant complications through optimized monitoring.
• Partnerships involving transplant centers, device manufacturers, and logistics providers are yielding integrative workflows and setting new standards in service delivery across the preservation continuum.
• Evolving regulatory frameworks create both challenges and incentives as agencies emphasize stringent standards, encouraging evidence-backed protocols and differentiation in vendor capabilities.
• Investment strategies are increasingly shaped by the adoption of value-based care models, which prioritize improved patient outcomes alongside operational efficiency.
• Diversification of supplier bases and regionally adapted technology implementations are helping market participants navigate shifting economic and competitive pressures across global regions.

Tariff Impact on Supply Chain and Manufacturing Dynamics

The introduction of new United States tariffs in 2025 has increased production costs for perfusion devices and accessories, prompting suppliers to reassess pricing and source alternatives. Manufacturers are embracing near-shoring and diversification, while healthcare institutions adapt procurement cycles and reinforce long-term service contracts to manage cost volatility. Cross-border collaboration, bulk procurement, and advocacy for select tariff exemptions have become strategic imperatives to sustain innovation and market access.

Methodology & Data Sources

Research is based on a multi-source methodology: primary interviews with key stakeholders, comprehensive secondary review of literature and regulatory filings, and quantitative analysis from structured surveys. Rigorous triangulation and scenario validation ensure the reliability and relevance of the insights presented.

Why This Report Matters for Senior Leaders in Organ Preservation

• Informs critical investment decisions through granular market segmentation and benchmarking of technology-driven innovations.
• Enables proactive risk mitigation by detailing regulatory trends and tariff-related supply chain shifts.
• Supports the formation of robust growth strategies with actionable insights into competitive positioning, partnerships, and regional adaptation.

Conclusion

The organ preservation market is positioned for robust growth, driven by advanced technology adoption, effective collaborations, and adaptive regulatory frameworks. Industry leaders equipped with timely insights will be prepared to advance patient outcomes and operational resilience in this fast-evolving sector.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.